473 related articles for article (PubMed ID: 23303213)
21. Relationship of circulating chemerin and omentin levels with Th17 and Th9 cell immune responses in patients with asthma.
Zhou Q; Fu Y; Hu L; Li Q; Jin M; Jiang E
J Asthma; 2018 Jun; 55(6):579-587. PubMed ID: 28771382
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.
Motawi TMK; Mahdy SG; El-Sawalhi MM; Ali EN; El-Telbany RFA
Can J Physiol Pharmacol; 2018 Jan; 96(1):38-44. PubMed ID: 28957639
[TBL] [Abstract][Full Text] [Related]
23. Classical (adiponectin, leptin, resistin) and new (chemerin, vaspin, omentin) adipocytokines in patients with prediabetes.
Gateva A; Assyov Y; Tsakova A; Kamenov Z
Horm Mol Biol Clin Investig; 2018 Jan; 34(1):. PubMed ID: 29332012
[TBL] [Abstract][Full Text] [Related]
24. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
[TBL] [Abstract][Full Text] [Related]
25. Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial).
Derosa G; Catena G; Gaudio G; D'Angelo A; Maffioli P
Cytokine; 2020 Mar; 127():154947. PubMed ID: 31811995
[TBL] [Abstract][Full Text] [Related]
26. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM.
Souvannavong-Vilivong X; Sitticharoon C; Klinjampa R; Keadkraichaiwat I; Sripong C; Chatree S; Sririwichitchai R; Lertbunnaphong T
Acta Diabetol; 2019 Oct; 56(10):1121-1131. PubMed ID: 31076892
[TBL] [Abstract][Full Text] [Related]
27. Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome.
Shafer-Eggleton J; Adams-Huet B; Jialal I
Endocr Res; 2020 Nov; 45(4):241-245. PubMed ID: 32835545
[TBL] [Abstract][Full Text] [Related]
28. Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis.
Kiczmer P; Szydło B; Seńkowska AP; Jopek J; Wiewióra M; Piecuch J; Ostrowska Z; Świętochowska E
Folia Med Cracov; 2018; 58(2):77-87. PubMed ID: 30467436
[TBL] [Abstract][Full Text] [Related]
29. Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis.
Dağdelen D; Karadag AS; Kasapoğlu E; Wang JV; Erman H
Dermatol Ther; 2020 Nov; 33(6):e14378. PubMed ID: 33029930
[TBL] [Abstract][Full Text] [Related]
30. Chemerin is a novel adipokine associated with obesity and metabolic syndrome.
Bozaoglu K; Bolton K; McMillan J; Zimmet P; Jowett J; Collier G; Walder K; Segal D
Endocrinology; 2007 Oct; 148(10):4687-94. PubMed ID: 17640997
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels and leucocyte RNA expression of adipokines in young patients with coronary artery disease, in metabolic syndrome and healthy controls.
Smékal A; Václavík J; Stejskal D; Benešová K; Jarkovský J; Svobodová G; Richterová R; Švesták M; Táborský M
Cytokine; 2019 Oct; 122():154017. PubMed ID: 28416270
[TBL] [Abstract][Full Text] [Related]
32. Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.
Alfadda AA; Sallam RM; Chishti MA; Moustafa AS; Fatma S; Alomaim WS; Al-Naami MY; Bassas AF; Chrousos GP; Jo H
Mol Cells; 2012 Jun; 33(6):591-6. PubMed ID: 22544171
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.
Yilmaz Y; Yonal O; Kurt R; Alahdab YO; Eren F; Ozdogan O; Celikel CA; Imeryuz N; Kalayci C; Avsar E
Scand J Gastroenterol; 2011 Jan; 46(1):91-7. PubMed ID: 20809771
[TBL] [Abstract][Full Text] [Related]
34. Omentin: linking metabolic syndrome and cardiovascular disease.
Zhou JY; Chan L; Zhou SW
Curr Vasc Pharmacol; 2014 Jan; 12(1):136-43. PubMed ID: 22724476
[TBL] [Abstract][Full Text] [Related]
35. Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy.
Urbanová M; Dostálová I; Trachta P; Drápalová J; Kaválková P; Haluzíková D; Matoulek M; Lacinová Z; Mráz M; Kasalický M; Haluzík M
Physiol Res; 2014; 63(2):207-18. PubMed ID: 24397804
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.
Greulich S; Chen WJ; Maxhera B; Rijzewijk LJ; van der Meer RW; Jonker JT; Mueller H; de Wiza DH; Floerke RR; Smiris K; Lamb HJ; de Roos A; Bax JJ; Romijn JA; Smit JW; Akhyari P; Lichtenberg A; Eckel J; Diamant M; Ouwens DM
PLoS One; 2013; 8(3):e59697. PubMed ID: 23555749
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous adipose tissue biology in metabolic syndrome.
Jialal I; Devaraj S
Horm Mol Biol Clin Investig; 2018 Jan; 33(1):. PubMed ID: 29353263
[TBL] [Abstract][Full Text] [Related]
38. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
[TBL] [Abstract][Full Text] [Related]
39. The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity.
Zehsaz F; Farhangi N; Ghahramani M
Phys Sportsmed; 2016 Nov; 44(4):355-361. PubMed ID: 27737602
[TBL] [Abstract][Full Text] [Related]
40. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome.
Liu R; Wang X; Bu P
Diabetes Res Clin Pract; 2011 Jul; 93(1):21-5. PubMed ID: 21497934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
